Related Experiment Videos
A new mouse mutant with progressive motor neuronopathy
H Schmalbruch1, H J Jensen, M Bjaerg
1Institute of Neurophysiology, Panum Institute, University of Copenhagen, Denmark.
Abstract:
A new autosomal-recessive mouse mutant with progressive motor neuronopathy (pmn) is described. Homozygotes develop paralysis of the hindlimbs during the third week of life. Soon thereafter the forelimbs also become weak, and all mice die six to seven weeks after birth. Heterozygotes are normal. Skeletal muscles show neurogenic atrophy without histological signs of reinnervation. Axonal degeneration apparently starts at the endplates and is prominent in the sciatic nerve and its branches and the phrenic nerve. Axonal sprouts are abundant. There is no evidence of demyelination, and unaffected nerve fibers are normally myelinated. Sensory axons are spared. Almost all distal motor axons have disappeared in four to five weeks after birth. Ventral nerve roots show a reduced diameter of the largest fibers but no fiber deficits. The ventral horn cells show slight chromatolysis. The corticospinal tract is normal, but in terminally ill animals the fasciculus gracilis, the rubrospinal tract and possibly also reticulospinal fibers degenerate. The brain is histologically normal. The disease manifests itself in a dying-back fashion in the distal portion of the motor neurons and may represent an animal model of hereditary motor neuron diseases in man.
Insights
A novel mouse model exhibits progressive motor neuronopathy, leading to hindlimb paralysis and death by seven weeks. This genetic condition offers insights into human hereditary motor neuron diseases.
Area of Science:
- Neuroscience
- Genetics
- Animal Models
Background:
- Progressive motor neuronopathy (pmn) is a debilitating neurological condition.
- Understanding the genetic and molecular underpinnings of motor neuron degeneration is crucial for developing therapeutic strategies.
Purpose of the Study:
- To describe a newly identified autosomal-recessive mouse mutant exhibiting progressive motor neuronopathy.
- To characterize the pathological features and disease progression of this novel mouse model.
- To evaluate its potential as an animal model for human hereditary motor neuron diseases.
Main Methods:
- Phenotypic analysis of homozygous pmn mice, including motor function assessment and survival rates.
- Histological examination of skeletal muscles, peripheral nerves (sciatic, phrenic), ventral nerve roots, and central nervous system.
- Microscopic evaluation of axonal integrity, myelination, and neuronal cell bodies.
Main Results:
- Homozygous pmn mice develop progressive hindlimb paralysis by three weeks of age, followed by forelimb weakness and death by six to seven weeks.
- Neurogenic atrophy of skeletal muscles is observed, with degeneration originating at the endplates and affecting distal motor axons.
- Axonal degeneration is prominent in peripheral nerves, with abundant sprouting but no demyelination; sensory axons remain unaffected.
- Ventral horn cells show chromatolysis, and in late stages, degeneration of specific descending tracts occurs, while the brain remains histologically normal.
Conclusions:
- The pmn mouse mutant displays a progressive, distal dying-back motor neuropathy.
- This model accurately recapitulates key pathological features of hereditary motor neuron diseases in humans.
- The pmn mouse serves as a valuable genetic tool for investigating the mechanisms underlying motor neuron degeneration and for testing potential therapies.